This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Chronic laryngitis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Defined as presence of laryngitis for more than three weeks (1).

The incidence of chronic laryngitis is not well established but has been estimated as 3.47 diagnoses per 1000 people per year. (2)

  • is more common in males.
  • may be predisposed to by: (3)
    • smoking
    • drinking spirits
    • voice overuse, e.g. by teachers, singers
    • chronic upper airway infection, e.g. sinusitis
    • tuberculosis
    • constant exposure to irritants
  • clinical features
    • it is characterised by a hoarseness of voice that tires easily
    • throat may be uncomfortable and the patient may have to clear his throat constantly
    • on examination the cords are thickened and pink and the surrounding mucosa is often red and dry.
  • treatment
    • is resting of the voice and steam inhalations, although this is often ineffective
    • underlying cause has to be removed (1)
    • usually settles in a week or two (1)

References:

  1. Wood JM, Athanasiadis T, Allen J. Laryngitis. BMJ. 2014 Oct 9;349:g5827.
  2. Stein DJ, Noordzij JP. Incidence of chronic laryngitis. Ann Otol Rhinol Laryngol. 2013 Dec;122(12):771-4.
  3. Dworkin JP. Laryngitis: types, causes, and treatments. Otolaryngol Clin North Am. 2008 Apr;41(2):419-36.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.